Ash Bahl

Head of R&D at Carrick Therapeutics

Dr Bahl has 25 years of international Pharmaceutical experience leading collaborations in US, Japan, and Europe. His previous roles were with Eli Lilly (Vice President of External Innovation), AstraZeneca (Vice President Head of R&D New Opportunities) and Glaxo.

Dr Bahl did his first degree in Pharmacy at Kings College London, trained as a pharmacist at John Radcliffe Hospital Oxford and then a PhD in Immunology at University College London (UCL). Dr Bahl has delivered over 10 compounds into clinical development from his leadership of drug discovery projects in R&D. Dr Bahl has also helped in establishing pioneering collaboration with the Medical Research Council and NIH/NCATs in drug repositioning. Within Eli Lilly he led collaborations with the Chorus Unit and Lilly’s Venture funds, this resulted in creation of several new project focused companies.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.